These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 12865278)
1. Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis. Boige V; Castéra L; de Roux N; Ganne-Carrié N; Ducot B; Pelletier G; Beaugrand M; Buffet C Gut; 2003 Aug; 52(8):1178-81. PubMed ID: 12865278 [TBL] [Abstract][Full Text] [Related]
2. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. Blanc JF; De Ledinghen V; Bernard PH; de Verneuil H; Winnock M; Le Bail B; Carles J; Saric J; Balabaud C; Bioulac-Sage P J Hepatol; 2000 May; 32(5):805-11. PubMed ID: 10845668 [TBL] [Abstract][Full Text] [Related]
3. Mutations of the HFE gene in patients with hepatocellular carcinoma. Cauza E; Peck-Radosavljevic M; Ulrich-Pur H; Datz C; Gschwantler M; Schöniger-Hekele M; Hackl F; Polli C; Rasoul-Rockenschaub S; Müller C; Wrba F; Gangl A; Ferenci P Am J Gastroenterol; 2003 Feb; 98(2):442-7. PubMed ID: 12591066 [TBL] [Abstract][Full Text] [Related]
4. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence. Hellerbrand C; Pöppl A; Hartmann A; Schölmerich J; Lock G Clin Gastroenterol Hepatol; 2003 Jul; 1(4):279-84. PubMed ID: 15017669 [TBL] [Abstract][Full Text] [Related]
5. Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes. Natarajan Y; Patel P; Chu J; Yu X; Hernaez R; El-Serag H; Kanwal F Dig Dis Sci; 2023 Jan; 68(1):312-322. PubMed ID: 35790703 [TBL] [Abstract][Full Text] [Related]
6. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma. Lauret E; Rodríguez M; González S; Linares A; López-Vázquez A; Martínez-Borra J; Rodrigo L; López-Larrea C Am J Gastroenterol; 2002 Apr; 97(4):1016-21. PubMed ID: 12003382 [TBL] [Abstract][Full Text] [Related]
8. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis. Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570 [TBL] [Abstract][Full Text] [Related]
9. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma. Fracanzani AL; Fargion S; Stazi MA; Valenti L; Amoroso P; Cariani E; Sangiovanni A; Tommasini M; Rossini A; Bertelli C; Fatta E; Patriarca V; Brescianini S; Stroffolini T Blood Cells Mol Dis; 2005; 35(1):27-32. PubMed ID: 15894495 [TBL] [Abstract][Full Text] [Related]
10. Incidence of liver disease in people with HFE mutations. Willis G; Wimperis JZ; Lonsdale R; Fellows IW; Watson MA; Skipper LM; Jennings BA Gut; 2000 Mar; 46(3):401-4. PubMed ID: 10673304 [TBL] [Abstract][Full Text] [Related]
11. [The H63D mutation in the HFE gene is related to the risk of hepatocellular carcinoma]. Ropero P; Briceño O; López-Alonso G; Agúndez JA; González Fernández FA; García-Hoz F; Villegas Martínez A; Díaz-Rubio M; Ladero JM Rev Esp Enferm Dig; 2007 Jul; 99(7):376-81. PubMed ID: 17973580 [TBL] [Abstract][Full Text] [Related]
12. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma. Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061 [TBL] [Abstract][Full Text] [Related]
13. Mutations of the HFE gene and the risk of hepatocellular carcinoma. Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population. Ezzikouri S; El Feydi AE; El Kihal L; Afifi R; Benazzouz M; Hassar M; Chafik A; Pineau P; Benjelloun S Arch Med Res; 2008 Feb; 39(2):236-41. PubMed ID: 18164971 [TBL] [Abstract][Full Text] [Related]
15. Association of HFE gene C282Y and H63D mutations with liver cirrhosis in the Lithuanian population. Juzėnas S; Kupčinskas J; Valantienė I; Šumskienė J; Petrenkienė V; Kondrackienė J; Kučinskas L; Kiudelis G; Skiecevičienė J; Kupčinskas L Medicina (Kaunas); 2016; 52(5):269-275. PubMed ID: 27816425 [TBL] [Abstract][Full Text] [Related]
16. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. Erhardt A; Maschner-Olberg A; Mellenthin C; Kappert G; Adams O; Donner A; Willers R; Niederau C; Häussinger D J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300 [TBL] [Abstract][Full Text] [Related]
17. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes. Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997 [TBL] [Abstract][Full Text] [Related]
18. Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients. Pirisi M; Toniutto P; Uzzau A; Fabris C; Avellini C; Scott C; Apollonio L; Beltrami CA; Bresadola F Cancer; 2000 Jul; 89(2):297-302. PubMed ID: 10918159 [TBL] [Abstract][Full Text] [Related]
19. HFE gene mutations in patients with alcoholic liver disease. A prospective study from northwestern Poland. Raszeja-Wyszomirska J; Kurzawski G; Zawada I; Suchy J; Lubinski J; Milkiewicz P Pol Arch Med Wewn; 2010 Apr; 120(4):127-31. PubMed ID: 20424537 [TBL] [Abstract][Full Text] [Related]
20. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]